Status:
COMPLETED
Effect of Nanotechnology Structured Water Magnalife for the Prevention of Recurrent Urinary Tract Infections.
Lead Sponsor:
University of Sulaimani
Conditions:
Recurrent Urinary Tract Infection
Eligibility:
FEMALE
24-80 years
Phase:
NA
Brief Summary
This study investigates nanotechnology structured water magnalife in urology and to test its effects against lower urinary tract infections (UTI) in females.
Detailed Description
This study represents the first time to use nanotechnology structured water magnalife in urology and to test its effects against lower urinary tract infections (UTI) in females. Urinary tract infectio...
Eligibility Criteria
Inclusion
- ≥ 2 (two or more than two) UTI in the last 6 months
- ≥ 3 (three or more than three) UTI in the last 12 months
Exclusion
- immunotherapy
- radiotherapy
- malignancy
- steroids
- chronic infections
- chemotherapy
- immunosuppressive drugs
- anatomical abnormality of the urinary tract
- surgical operation the urinary tract
Key Trial Info
Start Date :
September 20 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 21 2017
Estimated Enrollment :
437 Patients enrolled
Trial Details
Trial ID
NCT04306731
Start Date
September 20 2014
End Date
April 21 2017
Last Update
March 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
College of Medicine, University of Sulaimani
Sulaymaniyah, Kurdistan Region, Iraq, 00964